'''Pirandamine''' ('''AY-23,713''') is a [[tricyclic]] [[chemical derivative|derivative]] which acts as a [[selective serotonin reuptake inhibitor]] (SSRI).<ref name="pmid1085452">{{cite journal | vauthors = Pugsley T, Lippmann W | title = Effects of tandamine and pirandamine, new potential antidepressants, on the brain uptake of norepinephrine and 5-hydroxytryptamine and related activities | journal = Psychopharmacology | volume = 47 | issue = 1 | pages = 33–41 |date=May 1976 | pmid = 1085452 | doi = 10.1007/BF00428698| url = }}</ref><ref name="pmid1088377">{{cite journal | vauthors = Lippmann W, Pugsley TA | title = Pirandamine, a relatively selective 5-hydroxytryptamine uptake inhibitor | journal = Pharmacological Research Communications | volume = 8 | issue = 4 | pages = 387–405 |date=August 1976 | pmid = 1088377 | doi = 10.1016/0031-6989(76)90039-4| url = }}</ref><ref name="pmid853871">{{cite journal | vauthors = Lippmann W, Seethaler K | title = Effects of tandamine and pirandamine, selective blockers of biogenic amine uptake mechanisms, on gastric acid secretion and ulcer formation in the rat | journal = Life Sciences | volume = 20 | issue = 8 | pages = 1393–400 |date=April 1977 | pmid = 853871 | doi = 10.1016/0024-3205(77)90367-8| url = }}</ref> It was investigated in the 1970s as a potential [[antidepressant]] but clinical development was not commenced and it was never marketed.<ref name="pmid1085452" /> Pirandamine is [[chemical structure|structurally]] related to [[tandamine]], which, in contrast, is a selective [[norepinephrine reuptake inhibitor]].<ref name="pmid1085452" /><ref name="pmid853871" />
